MedPath

MultiPoint Pacing Programming Guided by Noninvasive Hemodynamics

Not Applicable
Completed
Conditions
Heart Failure
Interventions
Device: CRT with MultiPoint Pacing
Procedure: Hemodynamic measurements for CRT device programming
Registration Number
NCT02064751
Lead Sponsor
Abbott Medical Devices
Brief Summary

The purpose of this study is to evaluate noninvasive hemodynamics with MultiPoint™ Pacing (MPP) and biventricular (BiV) pacing under various vector combinations and paced delays in patients receiving cardiac resynchronization therapy (CRT).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Be scheduled to undergo de novo implant of a St. Jude Medical CRT-D system
  • Be in NYHA II or III functional class with approved standard indication by ESC/EHRA Guidelines
  • Have the ability to provide informed consent for study participation and be willing and able to comply with the Clinical Investigation Plan (CIP) described evaluations and follow-up schedule
Exclusion Criteria
  • Have persistent or permanent atrial fibrillation
  • Have a recent myocardial infarction within 40 days prior to enrollment
  • Have undergone cardiac surgery or coronary revascularization procedure within 3 months prior to enrollment or be scheduled for such procedures in the following 12 months
  • Have had a recent Cerebrovascular Accident (CVA) or Transient Ischemic Attack (TIA) within 3 months prior to enrollment
  • Have had intravenous inotropic support in the last 30 days
  • Be scheduled or considered for heart transplantation over the next 12 months
  • Be less than 18 years of age
  • Be pregnant or plan to become pregnant over the next 12 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
MultiPoint PacingHemodynamic measurements for CRT device programmingCRT with MultiPoint Pacing
MultiPoint PacingCRT with MultiPoint PacingCRT with MultiPoint Pacing
Primary Outcome Measures
NameTimeMethod
Systolic blood pressure changes in hemodynamics during BiV pacing and MPPup to 6-months
Secondary Outcome Measures
NameTimeMethod
echocardiographic changes to MPP programming guided by noninvasive hemodynamic measurements6 months

End systolic volume will be assessed at 6-month follow-up visit and compared to that of baseline.

Trial Locations

Locations (4)

CHU Rennes

🇫🇷

Rennes, France

Fondazione IRCCS Policlinico San Matteo

🇮🇹

Pavia, Italy

Medizinische Universität Graz

🇦🇹

Graz, Austria

Niguarda Hospital

🇮🇹

Milan, Italy

© Copyright 2025. All Rights Reserved by MedPath